N‐acetylaspartic aciduria due to aspartoacylase deficiency — a new aetiology of childhood leukodystrophy
The DOI matches its Crossref record.
Abstract
We describe a male infant with psychomotor retardation and leukodystrophy who excretes large quantities of N‐acetylaspartate in his urine. A high CSF/plasma concentration ratio of N‐acetylaspartate indicates that this substance originates in the brain. Fibroblasts from the patient are deficient in aspartoacylase activity. It is proposed that the dysmyelination in the patient may be due to failure of N‐acetylaspartate to serve as a carrier of acetyl groups from mitochondria to the cytosol for lipogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology
Moffett, J. R., Ross, B., Arun, P., Madhavarao, C. N., & Namboodiri, A. M. A. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.12.003 · Cited by 1,405
Birken, D. L., & Oldendorf, W. H. (1989) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(89)80048-x · Cited by 779
Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies
Simmons, M. L., Frondoza, C. G., & Coyle, J. T. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90101-s · Cited by 626
N -Acetylaspartate in neuropsychiatric disorders
Tsai, G., & Coyle, J. T. (1995) · Progress in Neurobiology · doi:10.1016/0301-0082(95)00014-m · Cited by 422
Aspartoacylase deficiency and N‐acetylaspartic aciduria in patients with canavan disease
Matalon, R., Michals, K., Sebesta, D., Deanching, M., Gashkoff, P., Casanova, J., Optiz, J. M., & Reynolds, J. F. (1988) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320290234 · Cited by 404
Long-term follow-up after gene therapy for canavan disease
Leone, P., Shera, D., McPhee, S. W. J., Francis, J. S., Kolodny, E. H., Bilaniuk, L. T., Wang, D.-J., Assadi, M., Goldfarb, O., Goldman, H. W., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003454 · Cited by 307
Adapting brain metabolism to myelination and long‐range signal transduction
Hirrlinger, J., & Nave, K. (2014) · Glia · doi:10.1002/glia.22737 · Cited by 109
“Experimental evidence, including the phenotype of Aspa and Aralar mutant mice (Matalon et al., 2000; Ramos et al., 2011), supports the idea that neuronal NAA provides acetate residues to oligodendrocytes for synthesis of myelin lipids (Hagenfeldt et al., 1987).”
BackgroundClinical Applications Involving CNS Gene Transfer
Kantor, B., McCown, T., Leone, P., & Gray, S. J. (2014) · Advances in Genetics · doi:10.1016/b978-0-12-800149-3.00002-0 · Cited by 74
Developmental increase of aspartoacylase in oligodendrocytes parallels CNS myelination
Kirmani, B. F., Jacobowitz, D. M., & Namboodiri, M. A. A. (2003) · Developmental Brain Research · doi:10.1016/s0165-3806(02)00592-8 · Cited by 71
Francis, J. S., Wojtas, I., Markov, V., Gray, S. J., McCown, T. J., Samulski, R. J., Bilaniuk, L. T., Wang, D.-J., De Vivo, D. C., Janson, C. G., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.10.001 · Cited by 49
“…disease; Myelination; energy Introduction Canavan disease is an autosomal recessive leukodystrophy caused by deficiency in aspartoacylase (ASPA) (Hagenfeldt et al., 1987), an oligodenroglial enzyme (Baslow et al., 1999) (Madhavarao et al., 2004) (Dugas et al., 2006) (Francis et al., 2011)…”
BackgroundBrain neurochemical and hemodynamic findings in the NY1DD mouse model of mild sickle cell disease
Cui, M., Suzuka, S. M., Branch, N. A., Ambadipudi, K., Thangaswamy, S., Acharya, S. A., Billett, H. H., & Branch, C. A. (2017) · NMR in Biomedicine · doi:10.1002/nbm.3692 · Cited by 11
Metadata
- Authors
- Hagenfeldt, L., Bollgren, I., & Venizelos, N.
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 1986-11-11
- Volume
- 10
- Issue
- 2
- Pages
- 135-141
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W2018126501
- Cited by
- 121
- References
- 0
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.